Authors:
MOLLER HJ
GAGIANO CA
ADDINGTON DE
VONKNORRING L
TORRESPLANK JF
GAUSSARES C
Citation: Hj. Moller et al., LONG-TERM TREATMENT OF CHRONIC-SCHIZOPHRENIA WITH RISPERIDONE - AN OPEN-LABEL, MULTICENTER STUDY OF 386 PATIENTS, International clinical psychopharmacology, 13(3), 1998, pp. 99-106
Citation: Ej. Barnard et al., PATIENTS WITH CHRONIC MENTAL-ILLNESS ATTENDING OUTPATIENT GROUPS - FACTORS INFLUENCING COMPLIANCE, South African medical journal, 88(6), 1998, pp. 752
Citation: H. Berzewski et al., EFFICACY AND TOLERABILITY OF REBOXETINE COMPARED WITH IMIPRAMINE IN ADOUBLE-BLIND-STUDY IN PATIENTS SUFFERING FROM MAJOR DEPRESSIVE EPISODES, European neuropsychopharmacology, 7, 1997, pp. 37-47
Authors:
GAGIANO CA
MULLER FGM
BERK M
JOUBERT PM
BROWN RGCW
SCHALL R
Citation: Ca. Gagiano et al., MOCLOBEMIDE TWICE-DAILY IN THE TREATMENT OF MAJOR DEPRESSIVE EPISODE - A DOUBLE-BLIND, MULTICENTER COMPARISON WITH DIFFERENT 3 TIMES DAILY DOSAGE SCHEDULES, Journal of clinical psychopharmacology, 15(4), 1995, pp. 4-9
Citation: Ca. Gagiano et al., MOCLOBEMIDE IN CONTINUATION TREATMENT OF MAJOR DEPRESSIVE EPISODES - AN OPEN FOLLOW-UP-STUDY OVER 6 MONTHS, Journal of clinical psychopharmacology, 15(4), 1995, pp. 46-50
Citation: Rj. Nichol et al., EXPOSURE TO VIOLENCE IN CHILDREN REFERRED FOR PSYCHIATRIC EVALUATION, South African medical journal, 85(6), 1995, pp. 584-585
Citation: Ca. Gagiano et al., MOCLOBEMIDE TWICE-DAILY IN THE TREATMENT OF MAJOR DEPRESSIVE EPISODE - A DOUBLE-BLIND, MULTICENTER COMPARISON WITH DIFFERENT 3-TIMES-DAILY DOSAGE SCHEDULES, Clinical neuropharmacology, 17, 1994, pp. 190000001-190000008